Predictors of hospital readmissions in adult patients with sickle cell disease.

American journal of blood research Pub Date : 2023-12-25 eCollection Date: 2023-01-01
Laura H Santiago, Roberto B Vargas, Derek O Pipolo, Deyu Pan, Sweta Tiwari, Kaveh Dehghan, Shahrzad Bazargan-Hejazi
{"title":"Predictors of hospital readmissions in adult patients with sickle cell disease.","authors":"Laura H Santiago, Roberto B Vargas, Derek O Pipolo, Deyu Pan, Sweta Tiwari, Kaveh Dehghan, Shahrzad Bazargan-Hejazi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sickle cell disease (SCD) is the most common inherited blood disorder, affecting primarily Black and Hispanic individuals. In 2016, 30-day readmissions incurred 95,445 extra days of hospitalization, $152 million in total hospitalization costs, and $609 million in total hospitalization charges.</p><p><strong>Objectives: </strong>1) To estimate hospital readmissions within 30 days among patients with SCD in the State of California. 2) Identify the factors associated with readmission within 30 days for SCD patients in California.</p><p><strong>Methods: </strong>We conducted a retrospective observational study of adult SCD patients hospitalized in California between 2005 and 2014. Descriptive statistics and logistic regression models were used to examine significant differences in patient characteristics and their association with hospital readmissions.</p><p><strong>Results: </strong>From 2,728 individual index admissions, 70% presented with single admission, 10% experienced one readmission, and 20% experienced ≥ two readmissions within 30 days. Significant predictors associated with zero vs. one readmission were male gender (OR=1.37, CI: 1.06-1.77), Black ethnicity (OR=3.27, CI: 1.71-6.27) and having Medicare coverage (OR=1.89, CI: 1.30-2.75). Lower likelihood of readmission was found in those with a Charlson Comorbidity index of three or more (OR=0.53, CI: 0.29-0.97). For zero vs. ≥ two readmissions, significant predictors were male gender (OR=1.43, CI: 1.17-1.74), Black ethnicity (OR=6.90, CI: 3.41-13.97), Hispanic ethnicity (OR=2.33, CI: 1.05-5.17), Medicare coverage (OR=3.58, CI: 2.68-4.81) and Medi-Cal coverage (OR=1.70, CI: 1.31-2.20). Lower likelihood for having two or more readmissions were associated with individuals aged 65+ (OR=0.97, CI: 0.96-0.98) and those with self-payment status (OR=0.32, CI: 0.12-0.54).</p><p><strong>Conclusions: </strong>In California, male, Black, and Hispanic patients, as well as those covered by Medicare or Medi-Cal, were found to have an increased risk of hospital readmissions. Redirecting outpatient goals to address these patient populations and risk factors is crucial for reducing readmission rates.</p>","PeriodicalId":7479,"journal":{"name":"American journal of blood research","volume":"13 6","pages":"189-197"},"PeriodicalIF":0.0000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10784118/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of blood research","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sickle cell disease (SCD) is the most common inherited blood disorder, affecting primarily Black and Hispanic individuals. In 2016, 30-day readmissions incurred 95,445 extra days of hospitalization, $152 million in total hospitalization costs, and $609 million in total hospitalization charges.

Objectives: 1) To estimate hospital readmissions within 30 days among patients with SCD in the State of California. 2) Identify the factors associated with readmission within 30 days for SCD patients in California.

Methods: We conducted a retrospective observational study of adult SCD patients hospitalized in California between 2005 and 2014. Descriptive statistics and logistic regression models were used to examine significant differences in patient characteristics and their association with hospital readmissions.

Results: From 2,728 individual index admissions, 70% presented with single admission, 10% experienced one readmission, and 20% experienced ≥ two readmissions within 30 days. Significant predictors associated with zero vs. one readmission were male gender (OR=1.37, CI: 1.06-1.77), Black ethnicity (OR=3.27, CI: 1.71-6.27) and having Medicare coverage (OR=1.89, CI: 1.30-2.75). Lower likelihood of readmission was found in those with a Charlson Comorbidity index of three or more (OR=0.53, CI: 0.29-0.97). For zero vs. ≥ two readmissions, significant predictors were male gender (OR=1.43, CI: 1.17-1.74), Black ethnicity (OR=6.90, CI: 3.41-13.97), Hispanic ethnicity (OR=2.33, CI: 1.05-5.17), Medicare coverage (OR=3.58, CI: 2.68-4.81) and Medi-Cal coverage (OR=1.70, CI: 1.31-2.20). Lower likelihood for having two or more readmissions were associated with individuals aged 65+ (OR=0.97, CI: 0.96-0.98) and those with self-payment status (OR=0.32, CI: 0.12-0.54).

Conclusions: In California, male, Black, and Hispanic patients, as well as those covered by Medicare or Medi-Cal, were found to have an increased risk of hospital readmissions. Redirecting outpatient goals to address these patient populations and risk factors is crucial for reducing readmission rates.

镰状细胞病成年患者再次入院的预测因素。
背景:镰状细胞病(SCD)是最常见的遗传性血液疾病,主要影响黑人和西班牙裔人群。2016 年,30 天内再入院导致额外住院 95,445 天,住院总成本 1.52 亿美元,住院总费用 6.09 亿美元:1) 估计加利福尼亚州 SCD 患者 30 天内的再入院情况。2) 确定加利福尼亚州 SCD 患者 30 天内再入院的相关因素:我们对 2005 年至 2014 年期间在加利福尼亚州住院的成年 SCD 患者进行了一项回顾性观察研究。我们使用了描述性统计和逻辑回归模型来研究患者特征的显著差异及其与再入院的关联:结果:在2728名入院患者中,70%的患者仅有一次入院经历,10%的患者经历过一次再入院,20%的患者在30天内经历过≥两次再入院。男性性别(OR=1.37,CI:1.06-1.77)、黑人种族(OR=3.27,CI:1.71-6.27)和拥有医疗保险(OR=1.89,CI:1.30-2.75)是与零次与一次再入院相关的重要预测因素。Charlson合并症指数为3或以上的患者再入院的可能性较低(OR=0.53,CI:0.29-0.97)。对于零次再入院与≥两次再入院,男性(OR=1.43,CI:1.17-1.74)、黑人(OR=6.90,CI:3.41-13.97)、西班牙裔(OR=2.33,CI:1.05-5.17)、医疗保险(OR=3.58,CI:2.68-4.81)和加州医保(OR=1.70,CI:1.31-2.20)是重要的预测因素。65岁以上人群(OR=0.97,CI:0.96-0.98)和自费人群(OR=0.32,CI:0.12-0.54)发生两次或两次以上再入院的可能性较低:结论:在加利福尼亚州,男性、黑人和西班牙裔患者以及享受医疗保险或 Medi-Cal 的患者再次入院的风险增加。针对这些患者群体和风险因素调整门诊目标对降低再入院率至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American journal of blood research
American journal of blood research MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
14
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信